Comparative prognosis of pulmonary embolism in patients infected with COVID-19 and patients not infected with COVID-19 in Ouagadougou
Copyright © 2024 Elsevier Masson SAS. All rights reserved..
OBJECTIVE: the study's objective was to determine impact of COVID-19 on the prognosis of pulmonary embolism.
PATIENTS AND METHODS: An analytical multicenter cross-sectional study with retrospective data collection was carried out in three university hospitals and a private clinic in Ouagadougou from March, 2020 to July 2021. It included consecutive patients hospitalized for PE confirmed on chest CT angiography or by the association an acute cor pulmonale on echocardiography-Doppler with deep vein thrombosis on venous ultrasound-Doppler of the lower limbs and having carried out a COVID-19 test (RT-PCR or rapid diagnostic test). Control cases consisted of all COVID-19 negative PE cases. Data comparison was carried out using the Epi info 7 software. A univariate then multivariate analysis allowed the comparison of the prognosis of the two subpopulations. The significance level retained was p < 0.05.
RESULTS: 96 patients with COVID-19+ and 70 COVID-19- PE were included. The prevalence of PE in patients hospitalized for COVID-19 was 7.05%. The average patient age was 61.5±17 years for COVID-19+ patients and 49.6±15.9 years for COVID-19- patients. Pulmonary condensation syndrome (p=0.007), desaturation (p=0.0003) and respiratory distress syndrome (p=0.006) were more common in COVID-19+ patients. The hospital death rate was 27.1% in COVID-19+ patients and 10% in COVID-19- patients (p=0.0024). Age > 65 years and COVID-19 pneumonia were the independent factors of death.
CONCLUSION: COVID-19 is associated with clinical severity and excess mortality in patients with pulmonary embolism.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Annales de cardiologie et d'angeiologie - 73(2024), 2 vom: 09. Apr., Seite 101735 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Pronostic comparé de l'embolie pulmonaire chez les patients infectés au COVID-19 et les patients non infectés au COVID-19 à Ouagadougou |
|---|
| Beteiligte Personen: |
Kambiré, Y [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Burkina Faso |
|---|
| Anmerkungen: |
Date Completed 01.04.2024 Date Revised 01.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ancard.2024.101735 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368772381 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368772381 | ||
| 003 | DE-627 | ||
| 005 | 20240401232637.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.ancard.2024.101735 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1359.xml |
| 035 | |a (DE-627)NLM368772381 | ||
| 035 | |a (NLM)38387249 | ||
| 035 | |a (PII)S0003-3928(24)00014-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Kambiré, Y |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparative prognosis of pulmonary embolism in patients infected with COVID-19 and patients not infected with COVID-19 in Ouagadougou |
| 246 | 3 | 3 | |a Pronostic comparé de l'embolie pulmonaire chez les patients infectés au COVID-19 et les patients non infectés au COVID-19 à Ouagadougou |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2024 | ||
| 500 | |a Date Revised 01.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a OBJECTIVE: the study's objective was to determine impact of COVID-19 on the prognosis of pulmonary embolism | ||
| 520 | |a PATIENTS AND METHODS: An analytical multicenter cross-sectional study with retrospective data collection was carried out in three university hospitals and a private clinic in Ouagadougou from March, 2020 to July 2021. It included consecutive patients hospitalized for PE confirmed on chest CT angiography or by the association an acute cor pulmonale on echocardiography-Doppler with deep vein thrombosis on venous ultrasound-Doppler of the lower limbs and having carried out a COVID-19 test (RT-PCR or rapid diagnostic test). Control cases consisted of all COVID-19 negative PE cases. Data comparison was carried out using the Epi info 7 software. A univariate then multivariate analysis allowed the comparison of the prognosis of the two subpopulations. The significance level retained was p < 0.05 | ||
| 520 | |a RESULTS: 96 patients with COVID-19+ and 70 COVID-19- PE were included. The prevalence of PE in patients hospitalized for COVID-19 was 7.05%. The average patient age was 61.5±17 years for COVID-19+ patients and 49.6±15.9 years for COVID-19- patients. Pulmonary condensation syndrome (p=0.007), desaturation (p=0.0003) and respiratory distress syndrome (p=0.006) were more common in COVID-19+ patients. The hospital death rate was 27.1% in COVID-19+ patients and 10% in COVID-19- patients (p=0.0024). Age > 65 years and COVID-19 pneumonia were the independent factors of death | ||
| 520 | |a CONCLUSION: COVID-19 is associated with clinical severity and excess mortality in patients with pulmonary embolism | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Burkina Faso | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Embolie pulmonaire | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Pronostic | |
| 650 | 4 | |a Pulmonary embolism | |
| 700 | 1 | |a Millogo, G R C |e verfasserin |4 aut | |
| 700 | 1 | |a Kologo, K J |e verfasserin |4 aut | |
| 700 | 1 | |a Tall-Thiam, A |e verfasserin |4 aut | |
| 700 | 1 | |a Agossou, V |e verfasserin |4 aut | |
| 700 | 1 | |a Konaté, L |e verfasserin |4 aut | |
| 700 | 1 | |a Somé, H |e verfasserin |4 aut | |
| 700 | 1 | |a Diallo, I |e verfasserin |4 aut | |
| 700 | 1 | |a Yameogo, N V |e verfasserin |4 aut | |
| 700 | 1 | |a Samadoulougou, K A |e verfasserin |4 aut | |
| 700 | 1 | |a Zabsonré, P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales de cardiologie et d'angeiologie |d 1968 |g 73(2024), 2 vom: 09. Apr., Seite 101735 |w (DE-627)NLM000057096 |x 1768-3181 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2024 |g number:2 |g day:09 |g month:04 |g pages:101735 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ancard.2024.101735 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2024 |e 2 |b 09 |c 04 |h 101735 | ||